Skip to the page

Data / Drug companies / Calcium sulfate anhydrous

Calcium sulfate anhydrous: 3 companies and 12 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Calcium sulfate anhydrous is listed in the FDA National Drug Code Directory by 3 companies, with 12 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are pellet; solution, and the newest product started marketing on November 22, 2011.

The request: Get every company that lists calcium sulfate anhydrous in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
3
Products
12
Generic (ANDA) products
0 (0.0%)
Application numbers
0
Routes
Oral, Sublingual
Brand names
Calcarea Sulphurica, Calcarea Sulphurica 200CK, Calcarea Sulphurica 30C, D-123
openFDA record search
api.fda.gov

Companies that list calcium sulfate anhydrous

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Boiron9pelletUnapproved homeopathic productsMarch 3, 1983
Sevene USA2pelletUnapproved homeopathic productsNovember 22, 2011
Dna Labs, Inc.1solutionUnapproved homeopathic productsJanuary 1, 1990

Dosage forms

Dosage formProductsShare
Pellet1191.7%
Solution18.3%

Marketing categories

Marketing categoryProductsShare
Unapproved homeopathic products12100%

Pharmacologic classes

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.